ABUS stands for automated breast ultrasound, a screening technology that uses sound waves to create three-dimensional images of breast tissue. The FDA approved it in 2012 specifically as a supplemental tool for women with dense breasts, where standard mammograms can miss cancers hidden within the tissue. Adding ABUS to mammography catches an additional 2 to 4 cancers per 1,000 screenings that mammograms alone would miss.
How ABUS Works
Unlike a standard handheld ultrasound, where a technician manually moves a small probe across the skin, ABUS uses a wide transducer that sweeps across the breast automatically. This produces high-resolution, three-dimensional volume images covering a large portion of the breast in a single pass. Because the machine controls the movement rather than a person, the images are consistent and reproducible every time, regardless of who operates the equipment.
The scanned images are sent to a workstation where a radiologist reviews them later, scrolling through the 3D volume much like flipping through slices of a CT scan. This separation between the scan itself and the interpretation is a key difference from handheld ultrasound, where the person holding the probe is typically the one making real-time assessments.
Who Should Consider ABUS
ABUS is designed for women with heterogeneously dense or extremely dense breast tissue. These are the two highest density categories on the standard four-level scale used in mammography reports. About 40% of women fall into one of these groups. Dense breast tissue appears white on a mammogram, and because cancers also appear white, tumors can be effectively invisible on a standard mammogram in these women.
The American College of Radiology considers breast ultrasound (including ABUS) a potentially appropriate supplemental screening option across a range of risk levels for women with dense breasts, from average risk to high risk. It’s not a replacement for mammography. It’s an add-on meant to find cancers that mammography misses.
How Much More Cancer Does It Find?
The numbers are meaningful. A large meta-analysis found that adding ABUS to mammography increased cancer detection sensitivity by 6 to 35 percentage points and improved the cancer detection rate by 2.4 to 4.3 per 1,000 women with dense breasts. In one study of 4,000 women, the cancer detection rate doubled from 3.6 per 1,000 with mammography alone to 7.2 per 1,000 when ABUS was included.
The tradeoff is a higher recall rate. More images mean more findings that need a second look, and some of those turn out to be nothing. Studies have shown that the increased detection comes with higher false-positive rates and lower biopsy accuracy compared to mammography alone. In practical terms, this means you’re more likely to be called back for additional imaging or a biopsy that ultimately shows no cancer. For many women with dense breasts, that tradeoff is worth catching cancers earlier.
What the Scan Feels Like
The experience depends on which generation of ABUS system your facility uses. With newer prone systems, you lie face down on a table with your breast resting on a glass surface. Ultrasound gel is applied to the glass, and the transducer rotates beneath it in a circular motion, capturing a full 360-degree volume image in roughly 35 seconds per breast. The entire appointment, including positioning and data transfer, takes about 10 minutes.
With supine systems (the more common setup in the U.S.), you lie on your back while a technologist positions a large curved transducer on each breast. Three passes are typically needed per breast, covering different zones. A gentle compression keeps the transducer in contact with the skin, but it’s lighter than the compression used in mammography. No radiation is involved.
ABUS vs. Handheld Ultrasound
Handheld breast ultrasound has been available for decades and can also find cancers hidden in dense tissue. The problem is consistency. Handheld ultrasound is highly operator-dependent, meaning the results vary based on the skill and thoroughness of the person holding the probe. It’s also time-intensive, often requiring 15 to 30 minutes of direct scanning per patient.
ABUS solves both problems. The automated scanner produces standardized, reproducible images with a larger field of view, and it frees the technologist from needing specialized scanning expertise. The radiologist can then review the stored images at their own pace, compare them to prior exams more reliably, and share them for second opinions. This makes ABUS more practical for large-scale screening programs where hundreds or thousands of women need consistent exams.
Insurance Coverage
Coverage for ABUS varies. Many states have passed breast density notification laws requiring that mammography reports inform you if you have dense breasts. A smaller number of states, including Illinois, Connecticut, and New Jersey, have gone further by mandating that insurers cover supplemental screening for women with dense breasts. Indiana requires this coverage for state employees specifically.
If your state doesn’t mandate coverage, your insurance may still cover ABUS, but you may need a prior authorization or a referral noting your breast density category. It’s worth checking with your plan before scheduling, as out-of-pocket costs for the exam can range from a few hundred dollars upward depending on the facility.